跳至主要内容
临床试验/IRCT201703194010N18
IRCT201703194010N18已完成未知

The effect of citrulline supplementation on serum lipids, liver enzymes, inflammatory markers and hepatic steatosis in patient with nonalcoholic fatty liver disease

Shahid Beheshti University of Medical Sciences, National Nutrition and Food Technology Research0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Inclusion criteria for the study:
  • Age 18 and older;Concentrations of liver enzymes ALT and AST greater than 1.5 times normal;Evidence of nonalcoholic steatohepatitis in Fibroscan (Controlled Attenuation Parameter (CAP) score> 263);Have not a history of consumption alcohol more than 10 milligrams of per day for women and more than 20 mg per day for men;Not consume any dietary supplement in the past three months
  • not consume any hepatotoxic drugs such as phenytoin, lithium
  • Exclusion criteria:
  • Not continue to cooperation;Biliary diseases; autoimmune and cancer and inherited disorders affecting liver during the study;Those less than 10% supplemen at the end of the sixth and twelth week consume.

排除标准

  • 未提供

研究者

发起方
Shahid Beheshti University of Medical Sciences, National Nutrition and Food Technology Research

相似试验